Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack
Doximity's stock has fallen 66% from $65 to $25, driven by market overreaction and short-term concerns rather than weakening fundamentals. The company maintains strong profitability with 90% gross margins, ~30% net margins, and robust cash flow, supported by its dominant network among U.S. healthcare professionals. Growth has slowed amid uncertainty around pharma advertising budgets and AI monetization, but the business remains asset-light with limited downside risk. It is considered a cautious buy due to undervaluation, resilience, and a durable competitive moat.
- ▪Doximity's stock price dropped from $65 to $25 over six months, a decline of about 66%.
- ▪The company reports 90% gross margins and approximately 30% net profit margins.
- ▪Doximity generates strong cash flow and maintains a leading network among U.S. physicians.
- ▪Recent pressure on the stock stems from pharma budget concerns and questions about AI monetization.
- ▪The author rates DOCS a cautious BUY, citing undervaluation and a solid economic moat.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895323-doximity-buy-it-as-mr-market-is-selling-it-cheap-under-a-panic-attack"},"author":{"@type":"Person","name":"Louis…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
